NFATC1

There are 153 papers on NFATC1 in aging research: 8 observational studies in people, 125 in animals, 18 in cells, 2 reviews. The newest story, Nov 13, 2026: “Bile acid reduced bone loss in mice with ovaries removed”.

Gene

153 papers study it15 findings

HGNCNCBI GeneTaxon

9 new papers in 30 daysSee all 153 papers on NFATC1

At a glance

The findings reach people, from one lab or study. 13 independent labs in 3 countries.

“NFATc1 is significantly upregulated in HCC tissues compared to adjacent non-cancerous tissues”
NFATc1 facilitates hepatocellular carcinoma progression by regulating the senescence-associated secretory phenotypeScientific reports2025doi:10.1038/s41598-025-07585-3

None of its findings points the other way.

Cells, mice and humans: a single group. Worms or flies: nothing yet.
  • 13 independent labs in 3 countries
  • Funders: National Natural Science Foundation of China and others
  • 1 of 15 findings with company ties
  • Humans8
  • Animals125
  • Cells18

Interventions

6

Sigma anti-bonding calcium

downin mouse cells1

1 study
  1. Sigma anti-bonding calcium decreases NFATC1 in RANKL-stimulated RAW264.7 cells.

    “attenuated NFATc1 protein induction”

    Cellsin RANKL-stimulated RAW264.7 cells

    Sigma Anti-bonding Calcium Attenuates Ovariectomy-Induced Bone Loss by Preserving Trabecular Microarchitecture and Suppressing Osteoclastogenesis

    Calcified tissue international

More on Sigma anti-bonding calcium

Anemarrhena asphodeloides + phellodendron chinense

downin mice1

1 study
  1. Anemarrhena asphodeloides + phellodendron chinense decreases NFATC1 in mice (ovariectomized mice; compared with either herb alone).

    “The effects of AA/PC were better than AA or PC alone on inhibiting the bone resorption marker nuclear factor of activated T-cells 1.”

    Animalsovariectomized mice; compared with either herb alonefemales

    Synergistic anti-osteoporosis effects of Anemarrhena asphodeloides bunge-Phellodendron chinense C.K. Schneid herb pair via ferroptosis suppression in ovariectomized mice

    Frontiers in pharmacology

More on Anemarrhena asphodeloides + phellodendron chinense

C1QBP

downin mouse cells1

1 study
  1. C1QBP decreases NFATC1 in mouse cells.

    “Additionally, recombinant C1qbp repressed the protein level but not the mRNA level of NFATc1.”

    Cellsrecombinant

    Extracellular C1qbp inhibits myogenesis by suppressing NFATc1

    Scientific reports

More on C1QBP

Liquiritin

downin mouse cells1

1 study
  1. Liquiritin inhibits NFATC1 in mouse cells (RANKL-induced).

    “LIQ markedly inhibited RANKL-induced NFATc1 activation”

    CellsRANKL-induced

    A novel Glycyrrhiza glabra extract liquiritin targeting NFATc1 activity and ROS levels to counteract ovariectomy-induced osteoporosis and bone loss in murine model

    Frontiers in pharmacology

More on Liquiritin

Oroxylin A

downin mouse cells1

1 study
  1. Oroxylin A inhibits NFATC1 in mouse cells (RANKL-induced osteoclastogenesis).

    “OA inhibited the activity of NFATc1, the master transcriptional regulator of RANKL-induced osteoclastogenesis.”

    CellsRANKL-induced osteoclastogenesis

    Oroxylin A reduces osteoclast formation and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation

    Biochemical pharmacology

More on Oroxylin A

Luteolin and apigenin

upin human cells1

1 study
  1. Luteolin and apigenin increases NFATC1 in human cells.

    “PCR arrays profiled multiple signals in PDLCs with luteolin/apigenin treatment, among which NFATc1 was the major upregulated gene”

    Cellsperiodontal ligament cells

    Luteolin and apigenin activate the Oct-4/Sox2 signal via NFATc1 in human periodontal ligament cells

    Cell biology international

More on Luteolin and apigenin

Effects

7

Osteoclast differentiation

mediatesin cells1upin mouse cells1

2 studies
  1. NFATC1 increases osteoclast differentiation in mouse cells (shown by enforced NFATc1 expression in nitazoxanide-treated cells) (partial rescue).

    “enforced NFATc1 expression partly rescued the impaired osteoclast differentiation in NTZ-treated RAW264.7 cells.”

    Cellsshown by enforced NFATc1 expression in nitazoxanide-treated cellsRAW264.7

    Nitazoxanide, an Antiprotozoal Drug, Reduces Bone Loss in Ovariectomized Mice by Inhibition of RANKL-Induced Osteoclastogenesis

    Frontiers in pharmacology

  2. NFATC1 mediates osteoclast differentiation in cells (shown by NFATc1 over-expression rescuing fisetin's inhibition).

    “Considering the rescue of fisetin's inhibitory action by NFATc1 over-expression, the cascade of p38-c-Fos-NFATc1 could be strongly involved in the inhibitory effect of fisetin on osteoclast differentiation.”

    Cellsshown by NFATc1 over-expression rescuing fisetin's inhibition

    Fisetin Inhibits Osteoclast Differentiation via Downregulation of p38 and c-Fos-NFATc1 Signaling Pathways

    Evidence-based complementary and alternative medicine : eCAM

osteoclast differentiation

upin cells1

1 study
  1. NFATC1 increases osteoclast differentiation in cells (K612A substitution).

    “Consistent with this mechanism, the K612A substitution stabilized NFATc1 and enhanced osteoclastogenesis.”

    CellsK612A substitutionosteoclast

    Protein loss increases bone loss in an animal model

    Cell death discovery

Lung BRM cell accumulation

downin animals1

1 study
  1. NFATC1 decreases lung BRM cell accumulation after influenza infection.

    “the transcription factors NFATC1 (nuclear factor of activated T cells 1) and EGR2 (early growth response 2) repress lung BRM cell accumulation after influenza infection”

    Animalsafter influenza infectionlung

    The B cell receptor-mTOR signaling axis restricts the accumulation of lung tissue-resident memory B cells after influenza infection

    Science immunology

Senescence-associated secretory phenotype (SASP)

upin cells1

1 study
  1. NFATC1 activates senescence-associated secretory phenotype (SASP) in cells (independent of growth arrest).

    “NFATc1 activation correlates with NF-κB/TMP21 signaling and senescence-associated secretory phenotype (SASP) amplification”

    Cellsindependent of growth arrest

    NFATc1 facilitates hepatocellular carcinoma progression by regulating the senescence-associated secretory phenotype

    Scientific reports

More on Senescence-associated secretory phenotype (SASP)

Hepatocellular carcinoma progression

upin mice1

1 study
  1. NFATC1 increases hepatocellular carcinoma progression in mice.

    “Overexpression of NFATc1 enhanced HCC cell proliferation, migration, and invasion both in vitro and in vivo”

    Animalsliver

    NFATc1 facilitates hepatocellular carcinoma progression by regulating the senescence-associated secretory phenotype

    Scientific reports

Fibrogenic activation

is required forin human cells1

1 study
  1. NFATC1 is required for fibrogenic activation in human cells (PIM1 overexpression in normal human lung fibroblasts).

    “this effect was attenuated by NFATc1 inhibition”

    CellsPIM1 overexpression in normal human lung fibroblasts

    Transcriptional analysis of lung fibroblasts identifies PIM1 signaling as a driver of aging-associated persistent fibrosis

    JCI insight

Alopecia

downin mice1

1 study
  1. NFATC1 prevents alopecia in mice (deletion of Foxc1 and Nfatc1).

    “Deletion of Foxc1 and Nfatc1 recapitulates HF miniaturization and causes hair loss.”

    Animalsdeletion of Foxc1 and Nfatc1

    Escape of hair follicle stem cells causes stem cell exhaustion during aging

    Nature aging

More on Alopecia

Associations

1

Hepatocellular carcinoma

upin humans1

1 study
  1. NFATC1 is associated with hepatocellular carcinoma in clinical HCC samples.

    “NFATc1 is significantly upregulated in HCC tissues compared to adjacent non-cancerous tissues”

    Humansin clinical HCC sampleslivern = 289

    NFATc1 facilitates hepatocellular carcinoma progression by regulating the senescence-associated secretory phenotype

    Scientific reports

More on Hepatocellular carcinoma

Latest

Dec 2025: 1Jan 2026: 5Feb 2026: 4Mar 2026: 6Apr 2026: 4May 2026: 6Jun 2026: 5Jul 2026: 5Aug 2026: 9Sep 2026: 5Oct 2026: 9Nov 2026: 463 papers in 12 months
bioRxiv

Bile acid reduced bone loss in mice with ovaries removed

In a 45-day experiment, deoxycholic acid improved bone structure in mice whose ovaries had been removed to model bone loss after menopause.In a 45-day experiment, deoxycholic acid improved bone structure in mice whose ovaries had been removed to model bone loss after menopause.

Preprint: mouse studyBone loss
Phytomedicine

Natural compound curbs bone breakdown by lab-grown cells

Lab experiments found that carabrone reduced bone-resorbing activity while having limited effects on measured cell signals involved in coordinating bone formation.Lab experiments found that carabrone reduced bone-resorbing activity while having limited effects on measured cell signals involved in coordinating bone formation.

Animal cell studyBones and joints
Cell Death Discovery

Protein loss increases bone loss in an animal model

Removing PHF2 from certain bone marrow-derived cells increased bone-resorbing cell formation and deterioration of the spongy tissue inside bones.Removing PHF2 from certain bone marrow-derived cells increased bone-resorbing cell formation and deterioration of the spongy tissue inside bones.

Animal studyBones and joints
bioRxiv

Mouse coronavirus hastened bone loss in osteoporotic mice

In an experiment in female mice, infection accelerated bone breakdown at five days in animals with osteoporosis; mice without osteoporosis showed bone loss at 60 days.In an experiment in female mice, infection accelerated bone breakdown at five days in animals with osteoporosis; mice without osteoporosis showed bone loss at 60 days.

Preprint: mouse studyBones and joints
Materials Today Bio

Targeted RNA delivery alleviates bone loss in mice

In a mouse model of osteoporosis caused by ovary removal, bone-targeted engineered vesicles preserved bone structure and reduced bone-breakdown activity without causing…In a mouse model of osteoporosis caused by ovary removal, bone-targeted engineered vesicles preserved bone structure and reduced bone-breakdown activity without causing systemic toxicity.

Mouse studyBones and joints

See all 153 papers on NFATC1